MassMutual Private Wealth & Trust’s Denali Therapeutics DNLI Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.68K	Hold	143	–	–	﹤0.01%	1789
2026 Q1	$2.75K	Hold	143	–	–	﹤0.01%	1890
2025 Q4	$2.36K	Hold	143	–	–	﹤0.01%	1946
2025 Q3	$2.08K	Buy	143 +20	+16%	+$287	﹤0.01%	1970
2025 Q2	$1.72K	Sell	123 -25	-17%	-$352	﹤0.01%	1993
2025 Q1	$2.01K	Sell	148 -6	-4%	-$115	﹤0.01%	1912
2024 Q4	$3.14K	Hold	154	–	–	﹤0.01%	1694
2024 Q3	$4.49K	Hold	154	–	–	﹤0.01%	1415
2024 Q2	$3.58K	Sell	154 -11	-7%	-$211	﹤0.01%	1430
2024 Q1	$3.39K	Buy	165 +48	+41%	+$902	﹤0.01%	1385
2023 Q4	$2.51K	Buy	117 +84	+255%	+$1.66K	﹤0.01%	1434
2023 Q3	$681	Buy	33 +11	+50%	+$279	﹤0.01%	1752
2023 Q2	$649	Buy	+22	New	+$619	﹤0.01%	1734
2022 Q2	–	Sell	-26	Closed	-$1K	–	1561
2022 Q1	$1K	Buy	+26	New	+$895	﹤0.01%	1304

Other funds holding DNLI

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's DNLI Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 143 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

MassMutual Private Wealth & Trust first reported a position in DNLI in Q1 2022 and has held it in 14 quarters since. The position peaked at $4.49K in Q3 2024. 60 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

MassMutual Private Wealth & Trust held 143 shares of Denali Therapeutics worth $3.68K as of Q2 2026.
MassMutual Private Wealth & Trust left its Denali Therapeutics share count unchanged in Q2 2026.
Denali Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1789 holding.
MassMutual Private Wealth & Trust first reported a position in Denali Therapeutics in Q1 2022 and has held it in 14 quarters since.
MassMutual Private Wealth & Trust's Denali Therapeutics position peaked at $4.49K in Q3 2024.
60 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.